EdiGene Company
EdiGene is a clinical-stage biotechnology company focused on leveraging the cutting-edge genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of genetic diseases and cancer.
Headquarters:
China
Funding Status:
Early Stage Venture
Estimated Revenue:
$10M to $50M
Technology:
Rare Genetic Disorders
Founded Date:
2015
Industry:
Stem Cell Exhaustion